Mead Johnson to operate independently from Bristol-Myers

Bristol-Myers Squibb is divesting Mead Johnson Nutrition to concentrate on biopharmaceuticals. The deal allows Bristol-Myers' shareholders to "exchange some, none or all of their shares of Bristol-Myers Squibb common stock for shares of Mead Johnson common stock," the company said.

View Full Article in:

Chicago Tribune (tiered subscription model) · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA